These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

693 related items for PubMed ID: 10354266

  • 1. Is low plasma 25-(OH)vitamin D a major risk factor for hyperparathyroidism and Looser's zones independent of calcitriol?
    Ghazali A, Fardellone P, Pruna A, Atik A, Achard JM, Oprisiu R, Brazier M, Remond A, Morinière P, Garabedian M, Eastwood J, Fournier A.
    Kidney Int; 1999 Jun; 55(6):2169-77. PubMed ID: 10354266
    [Abstract] [Full Text] [Related]

  • 2. Are low plasma levels of 25-(OH)vitamin D a major risk factor for hyperparathyroidism independent of calcitriol in renal transplant patients?
    Lomonte C, Antonelli M, Vernaglione L, Cazzato F, Casucci F, Chimienti D, Bruno A, Cocola S, Verrelli EA, Basile C.
    J Nephrol; 2005 Jun; 18(1):96-101. PubMed ID: 15772930
    [Abstract] [Full Text] [Related]

  • 3. [Relative depletion in native vitamin D: a potential risk factor in Algerian hemodialysis patients with radiological evidence of hyperparathyroidism and osteomalacia independent of calcitriolemia].
    Atik A, Ghazali A, Achard JM, Rida Z, Oprisiu R, Brazier M, Leflon P, Gueris J, Morinière P, Sari Z, Fournier A.
    Nephrologie; 1997 Jun; 18(2):47-52. PubMed ID: 9182233
    [Abstract] [Full Text] [Related]

  • 4. Renal ostodystrophy during the developing stage of maintenance dialysis in Transylvania. Early development of periarticular calcifications and beta 2 microglobulin amyloidosis in spite of a relatively good prevention of secondary hyperparathyroidism.
    Oprisiu R, Bolosiu H, Boca I, Theodoru C, Elefterescu R, Brazier M, el Esper I, Leflon P, Ledeme C, Fournier A, Heinze V.
    Ann Med Interne (Paris); 1998 Mar; 149(2):67-75. PubMed ID: 11490527
    [Abstract] [Full Text] [Related]

  • 5. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 6. Renal osteodystrophy in dialysis patients: diagnosis and treatment.
    Fournier A, Oprisiu R, Hottelart C, Yverneau PH, Ghazali A, Atik A, Hedri H, Said S, Sechet A, Rasolombololona M, Abighanem O, Sarraj A, El Esper N, Moriniere P, Boudailliez B, Westeel PF, Achard JM, Pruna A.
    Artif Organs; 1998 Jul; 22(7):530-57. PubMed ID: 9684690
    [Abstract] [Full Text] [Related]

  • 7. A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial.
    Lips P, Duong T, Oleksik A, Black D, Cummings S, Cox D, Nickelsen T.
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1212-21. PubMed ID: 11238511
    [Abstract] [Full Text] [Related]

  • 8. Serum concentrations of 25-hydroxyvitamin D and its association with bone mineral density and serum parathyroid hormone levels during winter in urban males from Guiyang, Southwest China.
    Zhang Q, Shi L, Peng N, Xu S, Zhang M, Zhang S, Li H, Zhuang H, Gong M, Wu D, Wang R.
    Br J Nutr; 2016 Mar 28; 115(6):960-6. PubMed ID: 26843386
    [Abstract] [Full Text] [Related]

  • 9. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V, Torregrosa V.
    Nefrologia; 2008 Mar 28; 28 Suppl 3():67-78. PubMed ID: 19018742
    [Abstract] [Full Text] [Related]

  • 10. Vitamin D receptor genotype influences parathyroid hormone and calcitriol levels in predialysis patients.
    Marco MP, Martínez I, Amoedo ML, Borràs M, Saracho R, Almirall J, Fibla J, Fernández E.
    Kidney Int; 1999 Oct 28; 56(4):1349-53. PubMed ID: 10504487
    [Abstract] [Full Text] [Related]

  • 11. Measurement of PTH fragments for assessment of renal bone disease in hemodialysis patients.
    Fehr T, Garzoni D, Staub T, Binet I, Wüthrich RP.
    Kidney Blood Press Res; 2006 Oct 28; 29(3):175-81. PubMed ID: 16931896
    [Abstract] [Full Text] [Related]

  • 12. [Renal osteodystrophy (2): its treatment in renal insufficiency before dialysis].
    Hottelart C, Bako G, Oprisiu R, Georgita A, Presne C, Sarraj A, Morinière P, el Esper N, Fournier A.
    Nephrologie; 2000 Oct 28; 21(6):275-82. PubMed ID: 11117106
    [Abstract] [Full Text] [Related]

  • 13. [Review of the concept of vitamin D "sufficiency and insufficiency"].
    Gómez Alonso C, Naves Díaz M, Rodríguez García M, Fernández Martín JL, Cannata Andía JB.
    Nefrologia; 2003 Oct 28; 23 Suppl 2():73-7. PubMed ID: 12778859
    [Abstract] [Full Text] [Related]

  • 14. Effect of CAPD and hemodialysis on parathyroid function.
    Malberti F, Corradi B, Imbasciati E.
    Adv Perit Dial; 1996 Oct 28; 12():239-44. PubMed ID: 8865912
    [Abstract] [Full Text] [Related]

  • 15. [Renal osteodystrophy (3); its treatment in dialysis patients].
    Ghitu S, Oprisiu R, Benamar L, Said S, Tataru Albu A, Arsenescu I, el Esper N, Morinière P, Fournier A.
    Nephrologie; 2000 Oct 28; 21(8):413-24. PubMed ID: 11213385
    [Abstract] [Full Text] [Related]

  • 16. Renal function and 25-hydroxyvitamin D concentrations predict parathyroid hormone levels in renal transplant patients.
    Boudville NC, Hodsman AB.
    Nephrol Dial Transplant; 2006 Sep 28; 21(9):2621-4. PubMed ID: 16644777
    [Abstract] [Full Text] [Related]

  • 17. Plasma 1,25(OH)2D levels decrease in postmenopausal women with hypovitaminosis D.
    Rejnmark L, Vestergaard P, Heickendorff L, Mosekilde L.
    Eur J Endocrinol; 2008 Apr 28; 158(4):571-6. PubMed ID: 18362305
    [Abstract] [Full Text] [Related]

  • 18. Conversion from Intravenous Vitamin D Analogs to Oral Calcitriol in Patients Receiving Maintenance Hemodialysis.
    Thadhani RI, Rosen S, Ofsthun NJ, Usvyat LA, Dalrymple LS, Maddux FW, Hymes JL.
    Clin J Am Soc Nephrol; 2020 Mar 06; 15(3):384-391. PubMed ID: 32111702
    [Abstract] [Full Text] [Related]

  • 19. Plasma 1,25-dihydroxyvitamin D levels in primary hyperparathyroidism depend on sex, body mass index, plasma phosphate and renal function.
    Moosgaard B, Vestergaard P, Heickendorff L, Mosekilde L.
    Clin Endocrinol (Oxf); 2007 Jan 06; 66(1):35-42. PubMed ID: 17201799
    [Abstract] [Full Text] [Related]

  • 20. Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism.
    Moosgaard B, Vestergaard P, Heickendorff L, Melsen F, Christiansen P, Mosekilde L.
    Clin Endocrinol (Oxf); 2005 Nov 06; 63(5):506-13. PubMed ID: 16268801
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.